For the first time ever, the science of ultrasonics can now be used in hospitals and pharmaceuticals to help reduce airborne contagion spread, and maintain critical sterilisation, via the Portascanner® COVID-19 by Coltraco Ultrasonics. Maintenance of our rooms/wards has never been more pressing, as a December 2020 study showed that 56% of air samples taken from hospital hallways contain high levels of coronavirus (JAMA Network).
Existing methods for achieving pressurisation are disruptive – requiring patients to be moved, costly – bringing in third-party contractors, and ineffective – user cannot identify specific areas of leakage, leaving remedial action to inaccurate speculation. Whilst 2020 hit the pause button, innovation thrived. Coltraco Ultrasonics applied 30 years of expertise to design a solution to help the NHS fight COVID-19 which resulted in winning a UK-Government funded Emergency Response Grant. Seven months later, Coltraco Ultrasonics proudly present a solution to improve air quality and protect staff and patients against the spread of airborne diseases, such as SARS-CoV-2 and beyond.
Portascanner® COVID-19 is a non-invasive answer to ‘patch and hope’ measures. With minimal training this maintenance equipment allows the user to efficiently locate and then quantify the leaks, as small as 0.5mm in diameter.
The air flow rate can then be calculated, generating an air permeability value for an entire cleanroom or hospital ward. The healthcare sector can now go above and beyond standards, with the ability to photograph, record, and export test reports, all in the tap of a finger. Maintaining pressurisation for the control of infectious diseases, and sterilisation for hazardous drugs has never been more pertinent. Portascanner® COVID-19 provides a hand-held solution that gives you confidence in the security of your room or ward, and the safety of its people.